Evidence map›Paper›PMID 23060149›Full record

ArticleThe Prostate2013

Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.

Nicole Strong, Ana C Millena, Lindsey Walker, Jaideep Chaudhary, Shafiq A Khan

Open access · greenAbstract read
In one paragraph

Article in The Prostate, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Alterations in TGFβ signaling during prostate cancer progression.American journal of clinical and experimental urology · 2021
    Review
  7. Article
  8. Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy.International journal of medical sciences · 2020
    Review
  9. Role ofMolecular vision · 2020
    Article
  10. Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy.International journal of molecular sciences · 2019
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nicole StrongCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia 30314, USA.
Ana C Millena
Lindsey Walker
Jaideep Chaudhary
Shafiq A Khan
Center for Cancer Research · US

Funding

THEORY OF PLANNED BEHAVIOR VS ETHNICITY /PHYSICAL ACTIVIG12RR003062 · NCRR · CLARK ATLANTA UNIVERSITY · PI CHAUDHARY, JAIDEEP · 1985 to 2011
$15.5M
TRAINNING COREP20MD002285 · NIMHD · CLARK ATLANTA UNIVERSITY · PI CHAUDHARY, JAIDEEP · 2007 to 2016
$10.9M
Inhibitor of Differentiation Gene Expression and Function in Prostate CellsR01CA128914 · NCI · CLARK ATLANTA UNIVERSITY · PI CHAUDHARY, JAIDEEP · 2009 to 2013
$1.4M
NCI NIH HHS R01 CA128914NCRR NIH HHS G12 RR003062NCRR NIH HHS G12RR003062NIMHD NIH HHS P20 MD002285NIMHD NIH HHS P20MD002285
6 · The paper itself

Abstract

backgroundIn prostate cancer cells, transforming growth factor β (TGFβ) inhibits proliferation in earlier stages of the disease; however, the cancer cells become refractory to growth inhibitory effects in advanced stages where TGFβ promotes cancer progression and metastasis. Inhibitor of differentiation (Id) family of closely related proteins (Id1-Id4) are dominant negative regulators and basic helix loop helix (bHLH) transcription factors and in general promote proliferation, and inhibit differentiation. In the present study, we have investigated the role of Id1 and Id3 proteins in the growth inhibitory effects of TGFβ on prostate cancer cells.

methodsThe effect of TGF β on proliferation and Id1 and Id3 expression were investigated in PZ-HPV7, DU145, and PC3 cells. Id1 silencing through siRNA was also used in DU145 and PC3 cells to examine its role in anti-proliferative and migratory effects of TGFβ.

resultsTGFβ increased expression of Id1 and Id3 in all cell lines followed by a later down regulation of Id1 in PZ-HPV7 expression and DU145 cells but not in PC3 cells. Id3 expression remained elevated in all three cell lines. This loss of Id1 protein correlated with an increase of CDKNI p21. Id1 knockdown in both DU145 and PC3 cells resulted in decreased proliferation. However, while TGFβ caused a further decrease in proliferation of DU145, but had no further effects in PC3 cells. Knockdown of Id1 or Id3 inhibited TGFβ1induced migration in PC3 cells.

conclusionsThese findings suggest an essential role of Id1 and Id3 in TGFβ1 effects on proliferation and migration in prostate cancer cells.

Indexed as

Prostatic NeoplasmsCell DifferentiationCell Line, TumorCell MovementCell ProliferationEpithelial CellsGene Expression Regulation, NeoplasticGrowth InhibitorsHumansInhibitor of Differentiation Protein 1Inhibitor of Differentiation ProteinsMaleNeoplasm ProteinsRNA, Small InterferingTransforming Growth Factor beta1Growth InhibitorsID1 protein, humanID3 protein, humanInhibitor of Differentiation Protein 1Inhibitor of Differentiation ProteinsNeoplasm ProteinsRNA, Small InterferingTGFB1 protein, humanTransforming Growth Factor beta1

Identifiers

PMID23060149
PMCPMC4018743
OpenAlexW2080403839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.